# Northwest Biotherapeutics Inc: Form 8-K, filed Jul 31, 2026

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: 8-K
- Filed: 2026-07-31
- Accepted by EDGAR: Jul 31, 2026, 17:17 ET
- Period: 2026-07-29
- Accession: 0001104659-26-089293
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465926089293/tm2620800d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465926089293/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465926089293/tm2620800d1_8k.htm

Filed Jul 31, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-089293. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.